Press

MINDCURE Announces Financial Results for the First Quarter of Fiscal 2023

Oct 27 • 1 min read

Mind Cure Health Inc. (CSE: MCURO | TCQB: MCURF | FRA: 6MH) today announced its financial results for the three months ended August 31, 2022. All amounts are stated in Canadian dollars unless otherwise indicated. The special committee of the Company’s board of directors is continuing to explore, review and evaluate a broad range of strategic alternatives…

Silo Wellness Announces Subsidiary’s Branding Licensing Agreement Terminated

Oct 26 • 5 min read

Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), announced that its wholly-owned subsidiary SW Holdings, Inc.’s (“SWHI”) License Agreement with Marley Green, LLC (“Licensor”) dated November 20, 2020, has been terminated as of October 24, 2022, by the licensor due to SWHI ‘s failure to pay its guaranteed minimum royalties of USD$600,000…

Wellbeing Digital to Participate at this Years’ Wonderland Miami Conference

Oct 26 • 2 min read

Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF | (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO, will participate at this years’ Wonderland Miami Conference taking place on November 3 to November…

Reunion Neuroscience Opens the Market

Oct 26 • 1 min read

Greg Mayes, President & Chief Executive Officer; Nathan Bryson, Chief Science Officer, and other members of the Reunion Neuroscience Inc. (TSX: REUN) management team joined Karoline Hunter, Head, Company Services, Toronto Stock Exchange, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market. Watch the video here Previously the drug development division of Field…

Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami Conference

Oct 26 • 3 min read

Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that James Kuo, M.D. M.B.A, Vice President of R&D, will speak as a panelist at Wonderland: Miami, the largest business gathering in the psychedelic medicine sector. Silo Pharma is a sponsor of the three-day conference being…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441